China’s Livzon Takes Control of Vietnam Antibiotics Leader
China’s Livzon Pharmaceutical Group has acquired a 68% stake in Vietnam’s leading antibiotic manufacturer, Imexpharm, for $338 million. This deal highlights increasing Chinese investment in Vietnam’s healthcare sector and underscores the country’s growing role as a strategic pharmaceutical manufacturing hub.
This article requires PRO
This article is outside the free access window or is a special report. PRO unlocks it and the full archive.
Related articles
- CPV Central Committee Deliberates Talent Strategy and Party Reforms
The Communist Party of Vietnam Central Committee deliberated on a draft strategy for talent attraction and utilization, alongside reforms aimed at building a clean and strong Party and political system. Revisions to regulations on Party members' participation in investment and business activities were also discussed.
- Five Vietnamese Businesswomen Named Among Asia's Most Powerful
Five Vietnamese businesswomen have been recognized in Fortune's '100 Most Powerful Women in Asia' list. Pham Thu Huong, Vice Chairwoman of Vingroup, secured the highest position for Vietnam at 37th.
- World Bank Raises Viet Nam's GDP Growth Forecast to 7.4% Amid AI Boom
The World Bank has raised Viet Nam's GDP growth forecast for 2024 to 7.4%, driven by increased demand for AI-related products. While this is among the highest in the East Asia and Pacific region, the report highlights risks associated with the economy's high dependence on AI-related exports and global demand fluctuations.
- Vietnam Welcomes Over 17.7 Million International Visitors in Nine Months
Vietnam has welcomed over 17.7 million international visitors from January to September this year. This figure marks a significant recovery for the tourism sector and is expected to boost economic growth.